Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Q4 2025 vs. Q3 2025
How the institutions holding Clarus Therapeutics Holdings, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 25.4K | +25.4K |
| Value | $0 | $0 | $0 |
New holders (1)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Garton & Associates Financial Advisors LLC | 25,354 | $0 | 0.00% |
Sold out (0)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
None.